Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Joan Montaner Mar Hernández-Guillamon |
| Publication date | September 5, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |